{"id":634926,"date":"2026-01-06T14:48:29","date_gmt":"2026-01-06T19:48:29","guid":{"rendered":"https:\/\/www.singlecare.com\/blog\/?p=634926"},"modified":"2026-01-06T14:48:29","modified_gmt":"2026-01-06T19:48:29","slug":"anoro-ellipta-generic","status":"publish","type":"post","link":"https:\/\/www.singlecare.com\/blog\/anoro-ellipta-generic\/","title":{"rendered":"Anoro Ellipta generic: Availability, cost, and more"},"content":{"rendered":"

Anoro Ellipta<\/span><\/a> (umeclidinium\/vilanterol) is a brand-name prescription inhaler used for the long-term treatment of chronic obstructive pulmonary disease (COPD). <\/span>COPD<\/span><\/a> is a progressive disease, meaning treatment is often lifelong and may require treatment adjustments to adequately manage it. In 2023, 3.8% (about 1 in 26) of U.S. adults were diagnosed with COPD, according to the Centers for Disease Control and Prevention, and it\u2019s the fifth leading cause of death in the United States. But treatment can be expensive, which is why patients may wonder whether a less-expensive generic version may be available.<\/span><\/p>\n

Is there a generic for Anoro Ellipta?<\/span><\/h2>\n

Yes, there is a generic version of Anoro Ellipta, <\/span>umeclidinium-vilanterol<\/span><\/a>, which has been <\/span>approved by the Food and Drug Administration (FDA)<\/span> since April 2025.\u00a0<\/span><\/p>\n

What are the differences between brand-name and generic Anoro Ellipta?<\/span><\/h2>\n

Brand-name Anoro Ellipta and its generic are nearly the same. Both contain the same active ingredients (umeclidinium bromide and vilanterol trifenatate) and work the same way to help people with COPD.\u00a0<\/span><\/p>\n

\u201cWhen a generic drug is approved by the FDA, it must demonstrate bioequivalence to the brand-name drug, which means that the generic drug delivers the same amount of the active ingredients into the patient\u2019s bloodstream as the brand-name drug does. For inhaled medications, the FDA requires the generic to demonstrate device equivalence to make sure that the drug is delivered to the lungs with the same performance characteristics as the brand device. Therefore, there should be no difference in clinical efficacy between the generic umeclidinium-vilanterol and brand-name Anoro Ellipta,\u201d says <\/span>Michael Genovese<\/span><\/a>, MD, Chief Medical Officer at Ascendant New York in New York City.\u00a0<\/span><\/p>\n

In addition to being delivered the same way (through an Ellipta inhaler device), the two drugs also carry the same risks of side effects.\u00a0<\/span><\/p>\n

Appearance<\/span><\/h3>\n

Both Anoro Ellipta and generic umeclidinium-vilanterol look very similar, aside from labeling differences. The drugs come in the same dry powder inhaler device, known as the Ellipta inhaler, which is a disposable, light gray device with a red inhaler. Each device contains 30 doses.\u00a0<\/span><\/p>\n

Dosage forms<\/span><\/h3>\n

Anoro Ellipta and umeclidinium-vilanterol deliver the same dose, 62.5 mcg of umeclidinium bromide and 25 mcg of vilanterol trifenatate powder per use.\u00a0<\/span><\/p>\n

Warnings and side effects\u00a0<\/span><\/h3>\n

The generic and brand-name versions of Anoro Ellipta have the same contraindications, warnings, and risks of side effects. These drugs are contraindicated (not for) people who are allergic to milk proteins or any of its ingredients, and those who already use a <\/span>long-acting beta agonist<\/span><\/a> (LABA) drug such as <\/span>Serevent<\/span><\/a> (salmeterol) or <\/span>Brovana<\/span><\/a> (arformoterol).<\/span><\/p>\n

Anoro Ellipta and umeclidinium-vilanterol are LABA drugs that don\u2019t contain an inhaled corticosteroid (ICS). These drugs aren\u2019t recommended for people with asthma because the safety and effectiveness of LABA drugs without an ICS hasn\u2019t been studied. In addition, Anoro Ellipta and umeclidinium-vilanterol are only used as a maintenance treatment for COPD. People with worsening COPD symptoms should see their healthcare provider right away to help manage their symptoms adequately.\u00a0<\/span><\/p>\n

Other warnings of Anoro Ellipta and umeclidinium-vilanterol include:<\/span><\/p>\n